20n Overview
- Founded
-
2014
- Status
-
Out of Business
- Employees
-
5
- Latest Deal Type
-
Out of Business
20n General Information
Description
Developer of an open-source biotechnology platform intended to offer predicting DNA edits on synthetic biology. The company's platform permits users to get the DNA blueprint and predicting DNA edits to make molecules biologically and get DNA design that will allow them to make a custom fermentation organism, enabling researchers to identify new molecules or discover efficient ways to reach a product.
Contact Information
Primary Industry
Biotechnology
Other Industries
Information Services (B2C)
Application Software
Primary Office
- 2319 Grant Street
- Apartment 8, Berkeley
- San Francisco, CA 94703
- United States
20n Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 19-Oct-2017 | 00000 | Completed | Out of Business | ||
| 2. Accelerator/Incubator | 24-Mar-2015 | 00000 | 00000 | 00.000 | Completed | Generating Revenue |
| 1. Early Stage VC | Completed | Startup |
20n Patents
20n Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170211103-A1 | Biosynthetic production of choline, ethanolamine, phosphoethanolamine, and phosphocholine | Abandoned | 21-Jan-2016 | 0000000000 | |
| US-20170211104-A1 | Biosynthetic production of acetaminophen, p-aminophenol, and p-aminobenzoic acid | Abandoned | 21-Jan-2016 | 0000000000 | |
| US-20170211105-A1 | Biosynthetic production of carnosine and beta-alanine | Abandoned | 21-Jan-2016 | C12P13/005 |
20n Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
